Bristol Myers Squibb to present positive new data on lymphoma treatment
June 18, 2025Medical Communications, Research and Development Bristol Myers Squibbs, CAR T-cell therapy, International Conference on Malignant Lymphoma, Oncology, relapsed or refractory marginal zone lymphoma
Bristol Myers Squibb (BMS) has announced positive results from the TRANSCEND FL phase 2 study evaluating Breyanzi (lisocabtagene maraleucel; liso-cel) …
Captain T Cell joins Bayer Co.Lab Berlin to accelerate TCR therapies
June 18, 2025Analytical & Laboratory Services, Business Services, Research and Development Bayer Co.Lab, Bayer Co.Lab Berlin, Captain T Cell, Corporate, T-cell receptor therapy, laboratory services
Captain T Cell, a biotech company developing next-generation T-cell receptor (TCR)-based therapies for solid tumours, has announced its selection for …
EVerZom receives €3m funding from French government to industrialise exosome technology
June 18, 2025Research and Development BpiFfrance, Corporate, Crohn’s disease, EVerZom, France 2030, French government, age-related disorders, exosome therapy, neurodegenerative disease
EVerZom, a French biopharma company focused on exosome-based therapies, has announced it has received €3m in funding as part of …
Samra Turajlić appointed director of Cancer Research UK Manchester Institute
June 18, 2025Medical Communications, Research and Development Cancer Research UK, Cancer Research UK Manchester Institute, Oncology, The Royal Marsden NHS Foundation Trust, University of Manchester, cancer research
Cancer Research UK has announced the appointment of Samra Turajlić as the new director of the Cancer Research UK Manchester …
Smartphone app for treating depression launches in UK
June 17, 2025Clinical & Scientific, Freelancers NHS trusts, Psychiatry, Rejoyn, digital therapeutics, major depressive disorder, mental health
Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The …
Astoriom appoints Brittany Jackson as CFO
June 17, 2025Business Services Astoriom, Corporate, R&D sample stability and biorepository storage, cfo
Astoriom, a R&D sample stability and biorepository storage company, has appointed Brittany Jackson as chief financial officer (CFO). Jackson will …
Biotium launches new DNA gel analysis technology
June 17, 2025Business Services, Research and Development Biotium, Corporate, DNA gel analysis, DNAzure blue nucleic acid gel stain, glo-plate white photoactivation device, life sciences reagents
Biotium has announced the launch of its new glo-plate white photoactivation device, a compact LED-powered light box designed to support …
Scientists discover reason for resistance to bowel cancer treatment
June 17, 2025Research and Development Cancer Research UK, Oncology, The Institute of Cancer Research, bowel cancer, drug resistance
Scientists funded by Cancer Research UK have demonstrated what may cause some treatments to stop working in people living with …
Johnson & Johnson presents promising data on leukaemia treatment
June 16, 2025Medical Communications, Research and Development European Hematology Association, Janssen-Cilag, Johnson & Johnson, Oncology, chronic lymphocytic leukaemia, clinical trial
Janssen-Cilag, a Johnson & Johnson company, has announced results from a matching-adjusted indirect comparison presented at this year’s European Hematology …
GCI Health appoints Aneeb Sharif as EMEA head of policy
June 16, 2025Business Services, Medical Communications, Public Relations Corporate, EMEA Head of Policy, GCI Health, healthcare communications agency, healthcare policy analysis, patient advocacy, public affairs
Healthcare communications agency, GCI Health, has announced the appointment of Aneeb Sharif as Europe, Middle East and Africa (EMEA) head …
Roche advances treatment for Parkinson’s disease
June 16, 2025Research and Development Neurology, Parkinson's disease, Roche, clinical trials, neurodegenerative disease
Swiss biopharma, Roche, has announced its decision to proceed with phase 3 trials of prasinezumab, an investigational therapy for Parkinson’s …
Shilpa Medicare and Orion partner, expanding into European market
June 16, 2025Manufacturing and Production Corporate, Orion Corporation, Shilpa Biocare, Shilpa Medicare, commercial supply agreement, plasma protein, recombinant human albumin
Shilpa Biocare, a wholly owned subsidiary of Shilpa Medicare, has signed a commercial supply agreement with Finland-based Orion Corporation for …
Bristol Myers Squibb reports positive results for psoriatic arthritis treatment
June 13, 2025Medical Communications, Research and Development European Alliance of Associations for Rheumatology, Rheumatology, bristol myers squibb, clinical trial, psoriatic arthritis
Bristol Myers Squibb (BMS) has presented new data from its phase 3 POETYK PsA-1 trial, showing that Sotyktu (deucravacitinib) significantly …
EpiEndo publishes new data supporting glasmacinal’s potential in COPD
June 13, 2025Medical Communications, Research and Development Chronic Diseases, EpiEndo Pharmaceuticals, Fraunhofer Institute for Toxicology and Experimental Medicine, antimicrobial resistance, chronic obstructive pulmonary disease (COPD), lung disease
EpiEndo Pharmaceuticals has announced the publication of three peer-reviewed articles in Pulmonary Pharmacology and Therapeutics, highlighting the therapeutic potential of …
PM Society and CIM launch new leadership programme for pharma marketers
June 13, 2025Sales and Marketing CIM Fellowship, Chartered Institute of Marketing (CIM), Corporate, Marketing Excellence Industry Group, PM Society Awards, Pharmaceutical Marketing (PM) Society, Pharmacy, partnership
The Pharmaceutical Marketing (PM) Society has partnered with the Chartered Institute of Marketing (CIM) to launch the PMS & CIM …
Digital platform for hypertension management launches in Europe
June 13, 2025Business Services, Technical Consultancy Chronic Diseases, HealthTech, Newel Health, digital platform, high blood pressure, hypertension management, hypertension therapy
Newel Health, a European healthtech company specialising in digital medical devices, has announced that Amicomed, its digital platform for hypertension …
PL BioScience appoints Oliver Dick as chief technology officer
June 12, 2025Clinical trials supplies & documentation logistics, Manufacturing and Production, Research and Development Corporate, Devices, Human Platelet Lysate, PL Bioscience, animal-free cell culture, life sciences
PL BioScience, a German life sciences company specialising in the production and development of human platelet lysate (HPL) for cell …
Ascend granted certification for quality control testing at Munich facility
June 12, 2025Contract Manufacturing, Manufacturing Services, Manufacturing and Production Adeno-associated (AAV)-based gene therapy., Ascend Advanced Therapeutics, Devices, Pharmacy, adeno-associated gene therapy, contract development and manufacturing organisation, good manufacturing practice certification, manufacturing site
Ascend Advanced Therapies, a contract development and manufacturing organisation based in Maryland, US, has received good manufacturing practice (GMP) certification …
Chiesi partners with Key2Brain to develop therapies for rare neurodegenerative diseases
June 12, 2025Manufacturing and Production, Mergers and Acquisitions, Research and Development Chiesi Group, Key2Brain, Neurology, Rare Diseases, lysosomal storage disorders, neurodegenerative disease, partnership, ultra-rare disease
Italian biopharma, Chiesi Group, and Key2Brain, a Swedish biotech, have agreed to advance the development of two blood-brain barrier (BBB)-crossing …
Treatment for serious eye disease approved in Scotland
June 12, 2025Market Access, Marketing Services, Research and Development, Sales and Marketing LYTENAVA, Opthalmology, Scottish Medicines Consortium, clinical programme, european union, eye disease, market approval, strategic partnership, united kingdom, wet age-related macular degeneration
Outlook Therapeutics has announced the Scottish Medicines Consortium (SMC) approval of Lytenava (bevacizumab gamma) for the treatment of wet age-related …
